Core Viewpoint - XinNuoWei (300765) is expected to report a net profit attributable to shareholders of between -170 million to -255 million yuan for the year 2025, indicating a shift from profit to loss year-on-year [1] Group 1: Financial Performance - The company anticipates a significant decline in profitability for 2025, with a projected net loss compared to previous earnings [1] - The expected net loss range for 2025 is between -170 million to -255 million yuan [1] Group 2: Business Operations - In early November 2025, the company completed the acquisition of an additional 29% minority stake in its subsidiary, JuShi Bio, increasing its ownership to 80% [1] - JuShi Bio is currently not profitable due to substantial investments in its research pipeline, which will further impact the company's consolidated financial statements as the ownership stake increases [1]
新诺威2025年净利预亏1.7亿元至2.55亿元